Oxurion NV
XBRU:OXUR

Watchlist Manager
Oxurion NV Logo
Oxurion NV
XBRU:OXUR
Watchlist
Price: 0.24 EUR -4% Market Closed
Market Cap: 616.8k EUR
Have any thoughts about
Oxurion NV?
Write Note

P/E
Price to Earnings

-0.1
Current
-2.8
Median
21.3
Industry
Higher than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-0.1
=
Market Cap
616.8k EUR
/
Net Income
-11.4m EUR
All Countries
Close
Market Cap P/E
BE
Oxurion NV
XBRU:OXUR
616.8k EUR -0.1
FR
Pharnext SCA
OTC:PNEXF
6T USD -182 946.5
US
Abbvie Inc
NYSE:ABBV
320.2B USD 63
US
Amgen Inc
NASDAQ:AMGN
140.4B USD 33.2
US
Gilead Sciences Inc
NASDAQ:GILD
113.9B USD 903.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
104.9B USD -218.7
US
Epizyme Inc
F:EPE
94.1B EUR -467
AU
CSL Ltd
ASX:CSL
137B AUD 32.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.1B USD 17
US
Seagen Inc
F:SGT
39.3B EUR -54.1
NL
argenx SE
XBRU:ARGX
36.6B EUR -334.4
Earnings Growth PEG
BE
Oxurion NV
XBRU:OXUR
Average P/E: 209.9
Negative Multiple: -0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -182 946.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
63
72%
0.9
US
Amgen Inc
NASDAQ:AMGN
33.2
20%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
903.9
21%
43
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -218.7
14%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -467 N/A N/A
AU
CSL Ltd
ASX:CSL
32.2
18%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
13%
1.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.1 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -334.4 N/A N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
N/A
2-Years Forward
P/E
N/A
3-Years Forward
P/E
N/A